CSPC Innovation Pharmaceutical Co., Ltd announced a private placement to issue A shares on January 23, 2024. The shares subscribed in this raising of supporting funds must not be transferred within 6 months after the issuance. The transaction was approved by board of directors.

The transaction is subject to approval from company share holders, Shenzhen Stock Exchange and CSRC. The transaction included participation from more than 35 investors.